How quickly will I notice results?
Many people experience improvements within 3-5 weeks, such as reduced stiffness, better mobility, or more energy. The effect builds up over time with daily use.
Can I take SUKOFLEX® with other medication?
SUKOFLEX® is a natural food supplement. However, if you are taking prescription medication, we recommend consulting your doctor before starting any new supplement.
Is SUKOFLEX® vegan?
Yes. SUKOFLEX® rosehip powder is 100% plant-based, organic, and suitable for both vegans and vegetarians.
Yes. SUKOFLEX® rosehip powder is 100% plant-based, organic, and suitable for both vegans and vegetarians.
Yes. SUKOFLEX® is a natural food supplement that can also be taken by children. Pregnant and breastfeeding women may use the product as well, but we recommend consulting a healthcare professional for individual guidance.
How should I store the products?
Keep the products in a cool, dry place, away from direct sunlight. Always close the container tightly after use to protect freshness and potency.
Can I use SUKOFLEX® for my pet?
For animals we recommend SUKOVET®, which is our rosehip powder specially developed for pets. It offers the same natural benefits, tailored to support joint health and mobility in animals.
Where does SUKOFLEX® rosehip come from?
SUKOFLEX® s made from the unique genetic variety Rosa canina AP-4®, cultivated on organic plantations in the south of Chile. Every step from the selected mother plant to the finished SUKOFLEX® product on the shelf is 100% traceable.
Is SUKOFLEX® organic?
Yes. All AP-4® rosehips used in SUKOFLEX® rosehip powder are grown on certified organic rosehip plantations in southern Chile.
What are the active compunds in SUKOFLEX® rosehip powder?
Rosehip is naturally rich in a wide range of bioactive compounds with antioxidant and anti-inflammatory properties, which have been associated with beneficial effects in mild arthritis. Thee include polyphenols (such as flavonols and proanthocyanidins), beta-carotenes, vitamins and omega-3 and -6 fatty acids. The health effects are the results of this unique natural combination, not a single isolated compound.
The levels of these compunds depends on the genetic variety, climate, growing conditions and harvesting time.
How is SUKOFLEX® standardized?
SUKOFLEX® is standardized by the following to obtain a premium and trustful product:
- Selection of the AP-4® genetic mother plan
- Certified organic plantation
- Optimal growing conditions in the southern Chilean climate
- Harvest at a defined stage of ripeness
SUKOFLEX® is a 100 % natural and single-ingredient product. Because its effects arise from the combination of many natural ocurring compounds, standardization is based on plant origin, cultivation and harvest, not on isolating individual compounds.
What makes SUKOFLEX® different from other rosehip powders?
Galactolipids as potential anti-inflammatory compounds?
Galactolipids are a class of plant lipids that primarily include:
- Monogalactosyldiacylglycerols (MGDGs)
- Digalactosyldiacylglycerols (DGDGs)
MGDGs are present in rosehips, but they are not unique to rosehips. In fact, they occur in relatively high concentrations in several legumes (such as beans and peas) and leafy green vegetables including kale, leek, parsley, perilla, and spinach. (Recent Patents on Food, Nutrition & Agriculture, 2009, 1, 50-58).
Since MGDGs and DGDGs plays a key role in the photosynthesis, they are naturally found in much higher amounts in green photosynthetic plant tissues compared to non-green fruits like rosehips.
Although supplements from greens may have anti-inflammatory effects, these effects are generally attributed to their antioxidants and polyphenols, rather than to galactolipids themselves.
Galactolipids as potential anti-inflammatory compounds?
Galactolipids attracted scientific interest as potential anti-inflammatory compounds around 20 years ago. In an early cell culture study, monogalactosyldiacylglycerol (MGDG) extracted from rosehips was associated with an anti-inflammatory effect (J. Nat. Prod. 2003, 66, 994-995).
However, subsequent clinical studies in humans have not been able to link the anti-inflammatory effects of rosehip powder to its galactolipid content. More than 20 years after the first in vitro study, it has still not been confirmed that galactolipids in rosehip powder act as an active ingredient for relieving symptoms of mild arthritis. Unknown factors such as low bioavailability and degradation during digestion, which are not captured in in vitro studies, may help explain this discrepancy.
